Biomedical sciences

SRI Biosciences delivers next-generation drugs, diagnostics and devices to solve unmet medical needs. We work with partners to develop transformative approaches and platforms for the toughest therapeutic problems.

Our latest

Case Study

Intracellular delivery—now a reality for many types of therapeutics

Case Study The SynFini™ system

Automating chemical drug discovery and synthesis

Case Study

Formulating a solution to mass radiation exposure

Areas of expertise

Collaborative research

Neuroimaging and electrophysiological research
Sleep device design and validation
Adolescent development
Translational approaches using in vivo MRI
Translational neuroscience

Drug discovery

Technology platforms for new approaches to drug discovery
Small molecule and biologic therapies
AI-driven drug design
Target validation and assay development and screening
Lead identification, optimization and synthesis

Diagnostics and devices

Fiber-optic Array Scanning Technology (FAST) rare cell detection
High-speed hyperspectral imaging
Wearable sleep technology
Diagnostic biomarker discovery
SynFini: automated chemistry design and synthesis
Chemical and biological sensing solutions

Product development services

Pharmacology, efficacy and predictive ADMET
Safety, drug metabolism and pharmacokinetics
Formulation design
Clinical drug product manufacturing
Clinical trials

There are many talented researchers from various disciplines at SRI. This creates an exciting environment and fertile ground for cutting edge research thanks to the cooperation of different teams. This highly effective collaboration allows SRI to invent and develop unique and novel products and technologies.

Michal Avital-Shmilovici

Research Scientist, Biosciences Division

Platforms

SRI Biosciences’ highly specialized platforms marry the advantages of our cutting-edge research with our flexible biotech business model. Partner with us to leverage our rigorous early discovery and development to customize your specific applications.

FOX Three Molecular Guidance System™

Cell-selective, intracellular delivery of macromolecular therapeutics: Deliver essentially any cargo to selected cell types, and internalize into those cells to targeted subcellular locations.

Learn more

SynFini™

Suite of automated tools leverages AI to recreate and scale literature-reported synthesis procedures. Solutions focus on key areas of route design, reaction screening and optimization (RSO), and multi-step synthesis development.

Learn more

Techneins™

Non-natural polymers as synthetic affinity reagents and novel therapeutics

Learn more

Synthetic Lethals

AI-guided precision cancer therapy platform provides a new approach to finding targeted therapies for previously “undruggable mutations.”

Learn more

Our innovation strategies are built on more than 50 years of drug development and discovery experience. We’ve refined our ability to repeat biomedical discovery and catalyze innovation into new products.

Ian M. Colrain

President, Biosciences Division

Fields of research

We work with commercial, government and academic clients and partners to help save and improve lives worldwide. Our leading-edge R&D is concentrated in the following areas to solve important problems in prevention, diagnosis and treatment.